相关实验视频
Updated: Jul 11, 2025

04:34
Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis
Published on: June 15, 2011
18.3K
微RNA及其在静脉血栓栓塞并发症中的作用
Ilgiz Gareev1, Valentin Pavlov2, Weijie Du3,4
1Central Research Laboratory, Bashkir State Medical University, 3 Lenin Street, 450008 Ufa, Russia.
Diagnostics (Basel, Switzerland)
|November 14, 2023
概括
微RNAs (miRNAs) 在静脉血栓栓塞并发症 (VTCs) 中起着关键作用,包括深静脉血栓症 (DVT) 和肺栓塞 (PE). 研究强调miRNAs作为早期VTC诊断和新治疗点的潜在生物标志物.
科学领域:
- 分子医学是分子医学.
- 心血管疾病 心血管疾病
- 生物标志物发现发现
背景情况:
- 静脉血栓栓塞并发症 (VTCs),包括深静脉血栓塞 (DVT) 和肺栓塞 (PE),仍然是导致死亡的重要原因,在心血管疾病中排名第三.
- 尽管诊断和治疗方面取得了进展,但了解VTCs的分子基础对于改善患者的治疗结果至关重要.
- 微RNAs (miRNAs) 已经成为血栓形成的关键调节者,为治疗干预和诊断策略提供了新的途径.
研究的目的:
- 审查当前关于miRNAs在VTCs病变发生中的作用的文献.
- 探索miRNAs作为VTCs的诊断和预后生物标志物的潜力.
- 评估miRNAs作为管理VTCs的潜在治疗点.
主要方法:
- 关于miRNAs和VTCs现有研究的综合文献综述.
- 对有关miRNAs参与血栓形成机制的数据的分析.
- 评价循环miRNAs作为VTC检测的非侵入性生物标志物.
主要成果:
- 在了解miRNAs对VTC开发的贡献方面取得了重大进展.
- 循环中的miRNAs显示为可访问的,用于早期VTC诊断的非侵入性生物标志物.
- 越来越多地认识到miRNAs在VTC管理中的治疗潜力.
结论:
- miRNAs是VTCs底层分子过程的组成部分.
- 针对miRNAs为新型VTC疗法提供了一个有前途的战略.
- miRNAs代表了早期诊断和预后VTCs有价值的工具,可能改善患者的结果.
相关概念视频
Venous Thrombosis I: Introduction
11
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
11
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
12
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
12
Anticoagulant Drugs: Low-Molecular-Weight Heparins
719
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
719
Venous Thrombosis IV: Nursing Management
14
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
14

